207 related articles for article (PubMed ID: 37122007)
1. High affinity of β-amyloid proteins to cerebral capillaries: implications in chronic lead exposure-induced neurotoxicity in rats.
Liu LL; Shen X; Gu H; Zhao G; Du Y; Zheng W
Fluids Barriers CNS; 2023 May; 20(1):32. PubMed ID: 37122007
[TBL] [Abstract][Full Text] [Related]
2. Altered clearance of beta-amyloid from the cerebrospinal fluid following subchronic lead exposure in rats: Roles of RAGE and LRP1 in the choroid plexus.
Shen X; Xia L; Liu L; Jiang H; Shannahan J; Du Y; Zheng W
J Trace Elem Med Biol; 2020 Apr; 61():126520. PubMed ID: 32325398
[TBL] [Abstract][Full Text] [Related]
3. Increased beta-amyloid levels in the choroid plexus following lead exposure and the involvement of low-density lipoprotein receptor protein-1.
Behl M; Zhang Y; Monnot AD; Jiang W; Zheng W
Toxicol Appl Pharmacol; 2009 Oct; 240(2):245-54. PubMed ID: 19501112
[TBL] [Abstract][Full Text] [Related]
4. Lead-induced accumulation of beta-amyloid in the choroid plexus: role of low density lipoprotein receptor protein-1 and protein kinase C.
Behl M; Zhang Y; Shi Y; Cheng J; Du Y; Zheng W
Neurotoxicology; 2010 Sep; 31(5):524-32. PubMed ID: 20488202
[TBL] [Abstract][Full Text] [Related]
5. Increased β-amyloid deposition in Tg-SWDI transgenic mouse brain following in vivo lead exposure.
Gu H; Robison G; Hong L; Barrea R; Wei X; Farlow MR; Pushkar YN; Du Y; Zheng W
Toxicol Lett; 2012 Sep; 213(2):211-9. PubMed ID: 22796588
[TBL] [Abstract][Full Text] [Related]
6. Effect of High Cholesterol Regulation of LRP1 and RAGE on Aβ Transport Across the Blood-Brain Barrier in Alzheimer's Disease.
Zhou R; Chen LL; Yang H; Li L; Liu J; Chen L; Hong WJ; Wang CG; Ma JJ; Huang J; Zhou XF; Liu D; Zhou HD
Curr Alzheimer Res; 2021; 18(5):428-442. PubMed ID: 34488598
[TBL] [Abstract][Full Text] [Related]
7. LRP1 in brain vascular smooth muscle cells mediates local clearance of Alzheimer's amyloid-β.
Kanekiyo T; Liu CC; Shinohara M; Li J; Bu G
J Neurosci; 2012 Nov; 32(46):16458-65. PubMed ID: 23152628
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E increases cell association of amyloid-β 40 through heparan sulfate and LRP1 dependent pathways.
O'Callaghan P; Noborn F; Sehlin D; Li JP; Lannfelt L; Lindahl U; Zhang X
Amyloid; 2014 Jun; 21(2):76-87. PubMed ID: 24491019
[TBL] [Abstract][Full Text] [Related]
9. Chronic cerebral hypoperfusion alters amyloid-β transport related proteins in the cortical blood vessels of Alzheimer's disease model mouse.
Shang J; Yamashita T; Tian F; Li X; Liu X; Shi X; Nakano Y; Tsunoda K; Nomura E; Sasaki R; Tadokoro K; Sato K; Takemoto M; Hishikawa N; Ohta Y; Abe K
Brain Res; 2019 Nov; 1723():146379. PubMed ID: 31415766
[TBL] [Abstract][Full Text] [Related]
10. Lead exposure increases levels of β-amyloid in the brain and CSF and inhibits LRP1 expression in APP transgenic mice.
Gu H; Wei X; Monnot AD; Fontanilla CV; Behl M; Farlow MR; Zheng W; Du Y
Neurosci Lett; 2011 Feb; 490(1):16-20. PubMed ID: 21167913
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
Shackleton B; Crawford F; Bachmeier C
Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
[TBL] [Abstract][Full Text] [Related]
12. Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance.
Singh I; Sagare AP; Coma M; Perlmutter D; Gelein R; Bell RD; Deane RJ; Zhong E; Parisi M; Ciszewski J; Kasper RT; Deane R
Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14771-6. PubMed ID: 23959870
[TBL] [Abstract][Full Text] [Related]
13. Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-β42 by LRP1-dependent apolipoprotein E isoform-specific mechanism.
Ma Q; Zhao Z; Sagare AP; Wu Y; Wang M; Owens NC; Verghese PB; Herz J; Holtzman DM; Zlokovic BV
Mol Neurodegener; 2018 Oct; 13(1):57. PubMed ID: 30340601
[TBL] [Abstract][Full Text] [Related]
14. Copper Exposure Perturbs Brain Inflammatory Responses and Impairs Clearance of Amyloid-Beta.
Kitazawa M; Hsu HW; Medeiros R
Toxicol Sci; 2016 Jul; 152(1):194-204. PubMed ID: 27122238
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of chronic lead effects in the blood brain barrier system by DCE-CT.
Gu H; Territo PR; Persohn SA; Bedwell AA; Eldridge K; Speedy R; Chen Z; Zheng W; Du Y
J Trace Elem Med Biol; 2020 Dec; 62():126648. PubMed ID: 32980769
[TBL] [Abstract][Full Text] [Related]
16. Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: implications for Aβ accumulation in AD brain.
Owen JB; Sultana R; Aluise CD; Erickson MA; Price TO; Bu G; Banks WA; Butterfield DA
Free Radic Biol Med; 2010 Dec; 49(11):1798-803. PubMed ID: 20869432
[TBL] [Abstract][Full Text] [Related]
17. Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease.
Deane R; Zlokovic BV
Curr Alzheimer Res; 2007 Apr; 4(2):191-7. PubMed ID: 17430246
[TBL] [Abstract][Full Text] [Related]
18. The role of LRP1 in Aβ efflux transport across the blood-brain barrier and cognitive dysfunction in diabetes mellitus.
P X; Zz L; Gg J; Lp W; Cm B; Yl W; Chen MF; W L
Neurochem Int; 2022 Nov; 160():105417. PubMed ID: 36067928
[TBL] [Abstract][Full Text] [Related]
19. LRP1 Has a Predominant Role in Production over Clearance of Aβ in a Mouse Model of Alzheimer's Disease.
Van Gool B; Storck SE; Reekmans SM; Lechat B; Gordts PLSM; Pradier L; Pietrzik CU; Roebroek AJM
Mol Neurobiol; 2019 Oct; 56(10):7234-7245. PubMed ID: 31004319
[TBL] [Abstract][Full Text] [Related]
20. Endothelial LRP1 - A Potential Target for the Treatment of Alzheimer's Disease : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.
Storck SE; Pietrzik CU
Pharm Res; 2017 Dec; 34(12):2637-2651. PubMed ID: 28948494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
